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Abstract: The probiotic market is increasing world-wide as well as the number of products
marketed as probiotics. Among the latter, many products contain Streptococcus thermophilus strains at
several dosages. However, the scientific evidence that should support the probiotic status of those
S. thermophilus strains is often contradictory. This review analyses the scientific literature aimed to
assess the ability of S. thermophilus strains to survive the human gastrointestinal tract by discussing
the scientific validity of the methods applied for the bacterial recovery and identification from stool
samples. This review highlights that in most of the intervention studies reviewed, the identification
of S. thermophilus strains from stools was not carried out with the necessary taxonomic accuracy to
avoid their misidentification with Streptococcus salivarius, a common human commensal and a species
phylogenetically close to S. thermophilus. Moreover, this review highlights how critical the accurate
taxonomic identification of S. thermophilus in metagenomics-based studies can be.
Keywords: S. salivarius; probiotics; taxonomy; recovery in fecal samples; microbiota
1. Introduction
According to the current definition of probiotics, “live microorganisms that, when administered
in adequate amounts, confer a health benefit on the host” [1], the health-related probiotic traits (e.g.,
neurological, immunological, endocrinological e↵ects) must be associated to a specific strain and
depend on its viability (Live microorganisms) and dose administered (Adequate amounts). Nevertheless,
there are also general, so-called Core benefits shared across a genus (e.g., regulation of intestinal transit,
competitive exclusion of pathogens, normalization of perturbed microbiota) and species (e.g., direct
antagonism, vitamin synthesis, enzymatic activity) level [1].
Most of the scientific literature dealing with the probiotic role of Streptococcus thermophilus strains
starts from the assumption of the health benefit of yogurt consumption [2–5]. Yogurt is defined
as a fermented milk based on the association of S. thermophilus and Lactobacillus delbrueckii subsp.
bulgaricus. For this reason, strains belonging to these species have often been involved in scientific
studies aimed to demonstrate their probiotic traits [6–10]. Due to its safe use in food production over
the years, S. thermophiluswas granted ‘Generally Recognized as Safe’ (GRAS) status in the USA and
the ‘Qualified Presumption of Safety’ (QPS) status in the European Union [11]. Apart from being a
constituent of yogurt, which has o cially recognized probiotic properties (prerequisite is to contain
at least 108 colony-forming units (CFU)/g live microorganisms) [12], health benefits associated with
S. thermophilus include production of antioxidant compounds, risk alleviation for some types of cancer,
anti-inflammatory e↵ects, antimutagenic e↵ects and stimulation of the gut immune system [11–14].
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The mitigating e↵ect of yogurt consumption on lactose maldigestion has been o cially recognized
by European Food Safety Authority (EFSA) as a health claim [12]. In compliance with the Food
and Agriculture Organization/World Health Organization (FAO/WHO) [15] modified definition of
probiotics proposed by Hill and colleagues [1], such a beneficial e↵ect has been attributed to the
consumption of live bacterial cultures (S. thermophilus and L. delbrueckii subsp. bulgaricus) by several
investigators [16–18]. For these reasons, probiotic products that include S. thermophilus strains are
produced by multitudinous manufactures all over the world, such as those shown in Table 1. Most of
the reported products (Table 1) are blends of several strains belonging to di↵erent species of lactic
acid bacteria (e.g., Lactobacillus rhamnosus, L. acidophilus, L. bulgaricus, L. reuteri, Bifidobacterium bifidum,
B. breve), Bacillus spp. (e.g., Bacillus coagulans, Bacillus subtilis, Bacillus clauslii) or the probiotic yeast
Saccharomyces boulardii, with a CFU/dose ranging from 2 to 450 billion. Even though the market
o↵ers plenty of probiotic products containing S. thermophilus biomasses, the applicability of the term
probiotic for this species itself is still questioned [19] due to its sensitivity to gastrointestinal tract (GIT)
transit conditions.
Table 1. List of chosen probiotic products available on the international market containing
S. thermophilus strains.
Product Brand Name S. thermophilesStrain Manufacturer
Colony-Forming Units
(CFU)/Dose Country of Origin
Fermental n.d. ESI S.r.l. 2 bilions/capsule Italy
Floratrex n.d. Global Healing Center 75 bilion/0.8 g USA
Lactoflor AB n.d. Global Medic 500 billion/capsule Ecuador
Lactoflor Probiotic n.d. Lactoflor 2 billion/0.4 g Bulgaria
Multibiotics n.d. NutriZing 50 billions/g (capsules) UK
Neuflor Z57 (BCCM: LMGP-21908) Yamamoto nutrition 56 billion/0.8 g Italy
Nexabiotic Advanced n.d. DrFormulas 17.25 billion/capsule USA
NOW Probiotic-10 St-21 NOW Foods 50 billion/capsule USA
Oti Probioti SP4 O.T.I. O cine TerapieInnovative S.r.l. 25.2 billion/4 capsules Italy
Perfect Biotics n.d. Probiotic America 30 billion/capsule USA
Pro-100 Ultra n.d. Natures Aid 100 billion/capsule UK
PRO-30 Max n.d. Natures Aid 30 billion/capsule UK
PRO-B ACTIVE n.d. Lilly Drogerie 14 bilions/capsule Serbia
PROBIO7 n.d. PROBIO 4 billion/capsule UK
Probioguard n.d. Lamberts 4 billion/capsule UK
Probiona Plus n.d. Tauron Ventures GmbH 30 billion/capsule Germany
Probiotic supplement
with vitamins SD5207
L’Angelica Istituto
Erboristico
18 billions/1.8 g (soluble
sticks) Italy
Prodefen PXN 66 Italfarmaco S. A
10 billion L. rhamnosus +1
bilion (other strains)/1 g
(sachets)
Spain
Protexin Bio-Kult PXN 66 Probiotics InternationalL.t.d. 10 bilion/g (capsule) UK
Synbiotic365 UASt-09 United Naturals 20 billion/capsule Canada
Ultra-potency ST-21 Custom Probiotics 320 billion/0.8 g (powder) USA
Visbiome DSM24731 ExeGi Pharma 1125 billion/g (capsule) USA
Vivomixx DSM 24731 Mendes S.A. 450 billion/4.4 g (sachet) Switzerland
VSL#3 BT01 Actial Farmaceutica S.r.l.
450 billion/4.4 g (sachets)
112 billion/658 mg
(capsules)
45 billion/1.5 g (sticks)
Italy
Yovis Z57 (BCCM: LMGP-219089) AlfaSigma
50 billion/1.5 g (sachets)
50 billion/0.7 g (capsules)
25 billion/10 mL (falcons)
Italy
Abbreviations: n.d.: strain code not declared; DSM: German Collection of Microorganisms and Cell Cultures GmbH;
BCCM: Belgian Co-ordinated Collections of Micro-organisms.
The capability of surviving theGIT is generally considered a key feature of probiotic strains [1,20,21]
and must be rigorously assessed. As highlighted by the FAO/WHO [15], typical in vitro tests such
as resistance to gastric acidity and bile acid resistance require in vivo validation. One widespread
way of doing so is the recovery of viable cells in fecal samples after oral administration, but are
S. thermophilus strains easily recovered and correctly identified from stool samples? It is likely that
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other Streptococcus species, which inhabit the GIT, could be misidentified as S. thermophilus. Therefore,
those taxonomic and ecological aspects should be considered in the intervention studies where
S. thermophilus biomasses are administered, and in all the studies focused on the characterization of the
human microbiota by metagenomics approaches. We review the scientific literature aimed to assess the
ability of S. thermophilus strains to survive the human gastrointestinal tract by discussing the scientific
validity of the methods applied for the bacterial recovery and identification from stool samples.
2. Existing Knowledge on S. thermophilus Survival in the Gastrointestinal Tract (GIT)
Transit Conditions
Several studies attempted to assess the survival to the GIT of S. thermophilus by following
di↵erent approaches, including culture-dependent and -independent methods or a combination
of both [9,20,22–28] Mater et al. [20] quantified an orally administered streptomycin- and
rifampicin-resistant S. thermophilus strain in fecal samples by standard plating, showing its substantial
GIT survival in adults consuming yogurt. Similarly, Venturi et al. [22] described the recovery of
S. thermophilus after oral administration of a multi-strain probiotic preparation by standard plating and
also demonstrated the ability of S. thermophilus to survive the GIT. Subsequently, Brigidi et al. [23,24]
and Mimura et al. [26] performed an identification and enumeration of S. thermophilus (combining
both culture-dependent and -independent methods) from fecal samples after the administration of the
same multi-strain probiotic product or yogurt, where they were able to recover significant numbers of
S. thermophilus [23,24,26] as well as to demonstrate its colonization pattern [24]. By contrast, a study by
del Campo and colleagues [25] dealing with the recovery of S. thermophilus from fecal samples using
plating and polymerase chain reaction (PCR) assay provided negative results for the GIT survival of
S. thermophilus in humans during a crossover study after daily yogurt consumption for two weeks.
Afterwards, Elli et al. [27] again confirmed that S. thermophilus can be retrieved from human feces after
yogurt consumption. Later on, García Hernández and colleagues [9] revealed the GIT survival and
colonization pattern of S. thermophilus in some subjects by applying a direct viable count-fluorescence
in situ hybridization (DVC-FISH) method to fecal samples.
Since those studies gave contradictory results on the ability of S. thermophilus strains to survive
GIT conditions, some authors are still arguing if it should be considered as a probiotic, thus naming
S. thermophilus a Transient probiotic [11]. It must be noted that those di↵erences in GIT survival rates
observed in di↵erent studies could have also been generated by the genetic and phenotypic diversity
of S. thermophilus strains and/or by di↵erences in fermentation process parameters adopted for the
production of the biomasses or by di↵erences in the absolute number of live cells administered [29].
3. Other Streptococci That Inhabit the Human GIT Could Interfere with the Correct Identification
of S. thermophilus in Stool Samples
When attempting to recover Streptococcus thermophilus from fecal samples, one often neglected but
critical aspect is its phylogenetic similarity with two other closely related species, namely S. salivarius
and S. vestibularis [30]. These three species, which are genetically very similar [30], belong to the
S. salivarius subgroup of viridians streptococci. S. salivarius and S. vestibularis are commensal bacteria
of the oral and gastrointestinal cavities and of the genital tract [31]. The genetic similarity between
S. salivarius and S. thermophiluswas so high that the latter was previously classified as a subspecies of
S. salivarius (S. salivarius subsp. thermophilus), and it obtained the status of species on its own only in
1991 [32]. S. thermophiluswas described as an example of regressive evolution for the adaptation to
a food environment [33]. S. thermophilus has lost all pathogenic traits throughout its evolution and
adaptation to a well-defined, narrow ecological niche, the milk [33,34]. The regressive evolution of
S. thermophilus was supported by the finding of a vestige of pathogenesis-related genes (10% of the
total sequence), counterbalanced by the acquisition of relevant traits, like lactose and urea utilization,
that have allowed the assembly of a new genome organization suitable for the colonization of the dairy
niche [33,34]. The milk-driven speciation of S. thermophilus is also supported by the fact that this species
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is rarely, if ever, isolated outside the dairy environment [34]. However, the ability of S. thermophilus
strains to utilize sucrose [34] with an e ciency comparable to that of lactose utilization led it to be
hypothesized that this species could still be able to survive and grow in plant-based environments [35].
Sharing the same and being adapted to more natural and competitive niches, S. salivarius
and S. vestibularis show a higher degree of physiological resemblance compared to S. thermophilus.
For instance, S. salivarius and S. vestibularis have a higher capability to synthesize extracellular
compounds (e.g., adhesins, exopolysaccharides) that are associated with bacterial fitness, resistance,
biofilm formation and play a crucial role in cell adhesion, host colonization, or escape from the
host immune system [30]. Moreover, the production of active urease, generally related to both
health-associated and virulence factors is a common trait for all members of the S. salivarius group
of streptococci [36]. The urease gene clusters of S. thermophilus and S. salivarius have similar
organization (ureIABCDEFGMQO), with more complex transcriptional regulation in S. salivarius [37,38].
The well-known probiotic strain S. salivarius K12 is urease positive and can colonize the oral mucosae
of humans regulating the innate immune responses of human epithelial cells [39]. In the case of the
urease activity of S. thermophilus, Arioli and co-authors [40] observed that ammonia provided by urea
hydrolysis boosted lactic acid production in both S. thermophilus and in L. delbrueckii, thus proposing
urease activity as an altruistic cooperative trait. Regarding carbon sources utilization, S. salivarius can
make use of a wider spectrum of compounds including glucose, fructose, galactose, lactose, as well
as hydrolyze complex polymers such as starch or glucans [34]. On the other hand, S. thermophilus
is well adapted to lactose as the main carbon source, hydrolyzing it to the glucose and galactose
moieties. S. thermophilus is not able to metabolize galactose, expelling it outside the cell [34]. However,
some galactose positive strains are reported [41]. Recently, multilocus sequence typing (MLST) and
comparative genomic analysis gave novel insights into phylogeny, clearly separating these three species
as well as indicating that S. thermophilus probably deviated from S. vestibularis [30,42].
Concerning the safety aspect, there is an overall consensus on the safety status of S. thermophilus
species, whereas few reports highlighted that S. salivarius and S. vestibularis strains may cause mild to
severe human infections [43,44].
Streptococcus spp. represent a notable part of the intestinal microbiota, with S. salivarius as one
of the main species, indicating that these bacteria are actually able to colonize this ecological niche,
rather than just being washed down with the flow of saliva [30,45–47]. S. salivarius has been recovered
from fecal samples of infants, thus revealing that this species is one of the first inhabitants of the
human gut [48,49]. Moreover, Delorme et al. [30] pointed out that previous metagenomic analysis of
human feces revealed the presence of S. salivarius (formerly described as S. thermophilus due to a lack
of appropriate genomic references) in more than 90% of the individuals tested [30,50].
In the light of these considerations, the answer to the question “Could S. thermophilus be
misidentified with other streptococci that inhabit the human GIT?” is: yes, if the genomic similarities
between these species are not considered (Figure 1).
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Figure 1. Schematic representation of the criticisms associated to the identification of S.
thermophilus strains in human stool samples during intervention studies. Gb, gastric barrier; GIT,
gastrointestinal tract.
4. The Methods Applied in the Reviewed Literature to Identify S. thermophilus Strains Were Not
Selective at Species Level
We previously showed that some studies, dealing with the survival of S. thermophilus to the human
GIT, based their assumptions on the recovery of S. thermophilus from the stool of human subjects
after the consumption of yogurt or probiotic preparations [9,20,23–28]. Most of the studies indicated
substantial [9,20,23,24,26–28] or no survival [25] of S. thermophilus strains after consumption of yogurt
or probiotic products containing this species. What are the reasons for these contradictory conclusions?
In most of the studies, the authors have paid little attention to the culture-dependent methods applied
to recover live S. thermophilus strains from stool samples. The culture-dependent plating technique
on specific selective media (e.g., ST agar, ST agar supplemented with the pH indicators bromocresole
purple and bromocresole green, and the antibiotic nalidixic acid) used in some studies [22–24,28] was
shown [23] to be ine↵ective for the selective identification and enumeration of S. thermophilus after the
administration of a dairy or probiotic product, due to the inability to discriminate S. thermophilus from
intestinal streptococci and enterococci as well as the phylogenetically closely related S. salivarius [23].
Therefore, the possibility to misidentify S. thermophiluswith S. salivarius, the closest neighbor inhabiting
the oral cavity, was likely underestimated. In addition, competitive inhibition by autochthonous
bacteria from the gut, which may hinder the growth of S. thermophilus in the plate, cannot be excluded.
Mater and colleagues [20] tried to selectively isolate S. thermophilus S85, which was streptomycin and
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rifampicin resistant, by adding the two antibiotics to the medium used for the recovery from fecal
samples; however, the sensitivity of S. salivarius strains to streptomycin and rifampicin was not verified,
nor was a molecular identification performed on the isolated colonies to confirm their taxonomy.
Therefore, to date, the data about the accurate identification and retrieval of S. thermophilus in human
subjects upon administration of yogurt or probiotic preparations are debatable.
4.1. Are the Data Supporting the GIT Survival of S. thermophilus Strains Solid and Unbiased Enough to
Generate Scientific Consensus?
A list of molecular tools developed for the identification of S. thermophilus, together with the
limitations detected for each of them, is shown in Table 2. Some of the tools listed in Table 2 have been
developed aiming to identify S. thermophilus from fermented dairy products. These tools are based on
species-specific polymerase chain reaction (PCR) primers targeting the 16S rDNA gene sequence [51,52].
However, the 16S rDNA gene sequence is not specific enough because of a high identity among those
sequences in S. thermophilus, S. salivarius and S. vestibuilaris species (99.8% between S. thermophilus
and S. salivarius; 99.6% between S. thermophilus and S. vestibularis) [53]. Lick and Teuber [54] designed
species-specific oligonucleotide probes based on the 50 region of the lacZ gene, but they showed both
specific and non-specific hybridization signals among di↵erent strains of S. thermophilus and S. salivarius.
Later on, species-specific PCR primers targeting the lacZ gene were developed [55]. This primer set
was validated using several S. thermophilus strains and two S. salivarius strains as a reference [55].
However, subsequent studies demonstrated the inability of lacZ gene primers to correctly identify
S. thermophilus strains [27].
Table 2. Overview of tools used in interventional studies for viability assessment of S. thermophilus.
Product Used Tool TargetSpecies/Gene Species-Specificity
Other Potentially
Detected Species Reference
Probiotic food
supplement Standard plating S. thermophilus no
S. salivarius, S.
vestibularis [22]
Probiotic food
supplement End-point PCR
16S-23S rDNA
spacer region no
S. salivarius, S.
vestibularis [23]
Probiotic food
supplement and
Yogurt
End-point PCR,
qPCR
16S-23S rDNA
spacer region no
S. salivarius, S.
vestibularis [24]
Probiotic food
supplement End-point PCR
16S-23S rDNA
spacer region no
S. salivarius, S.
vestibularis [26]
Yogurt End-point PCR,DNA-hybridization lacZ gene no
S. salivarius, S.
vestibularis [25]
Yogurt End-point PCR,PFGE
lacZ gene, Profiles
of SmaI-digested
chromosomes
no S. salivarius, S.vestibularis [27]
Yogurt DVC-FISH 23S rRNA no S. salivarius, S.vestibularis [9]
Abbreviations: PCR: polymerase chain reaction; qPCR: quantitative polymerase chain reaction; PFGE: pulsed-field
gel electrophoresis.
In 1997, Tilsala-Timisjärvi and Alatossava [56] designed the ThI/ThII PCR species-specific primer
set, based on the internal transcribed spacer between the 16S and the 23S rDNA genes for the detection
of S. thermophilus in dairy products. In this study, the authors underlined that this primer set was most
probably not able to distinguish between S. thermophilus and S. salivarius, which, being a closely related
species, has an almost identical spacer sequence between the 16S rDNA and the 23S rDNA genes.
Subsequently, Mora and colleagues [41], analyzing the sequence of the 16S-23S rDNA spacer region,
demonstrated that a simple end-point PCR assay carried out using ThI/ThII primers was ine↵ective to
discriminate between S. salivarius, S. thermophilus, S. bovis, S. macedonicus, S. waius and S. infantarius
species. Nevertheless, the two primers were used in various intervention studies to carry out the
identification of S. thermophilus strains recovered from stool samples [23,24,26]. More specifically,
Brigidi et al. [23] performed an identification and enumeration of S. thermophilus from fecal samples of
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individuals who had been taking a multi-strain probiotic product using ThI/ThII primers, reporting a
significant increase of S. thermophilus after administration of this probiotic product. Later, the same
group of authors conducted a similar study using a culture-independent quantitative polymerase chain
reaction (qPCR) method with the same primer set (ThI/ThII) for the identification and enumeration of
several S. thermophilus strains showing its survival as well as colonization pattern after administration of
both a probiotic preparation and commercial yogurt [24]. However, quantitative PCR of S. thermophilus
was applied directly on feces, thus it was not possible to discriminate between live and dead cells as
well as free DNA originated from lysed cells. In this case, a propidium monoazide (PMA-qPCR)-based
methodology [57] would have been appropriate to directly quantify live S. thermophilus cells excluding
dead cells and free DNA from the fecal samples. Moreover, in this study the primers where accurately
tested for specificity against some intestinal and dairy species, among them S. faecium (several
strains), Lactobacillus acidophilus (several strains), L. brevis, L. casei, L. crispatus, L. delbrueckii subsp.
delbrueckii (several strains), L. delbrueckii subsp. lactis, Lactococcus lactis, (several strains), L. lactis
subsp. cremoris (several strains), L. lactis subsp. lactis biovar diacetylactis, Escherichia coli (several
strains), Enterococcus fecalis (several strains), Clostridium beijerinkii, C. perfringens, Bacteroides fragilis
(several strains), Bifidobacterium bifidum (several strains), B. infantis (several strains), B. longum (several
strains), B. adolescentis (several strains) but not against the phylogenetically close S. salivarius. Similarly,
Mimura et al. [26] demonstrated higher levels of S. thermophilus after administration of a multi-strain
probiotic product using the same primer set. These studies, based on the use of ThI/ThII primers, also
showed that some of the subjects harbored S. thermophilus even after the run in and prior to treatment
period, where the subjects were asked not to consume any food products containing this species.
Therefore, we can speculate that primers may have actually detected S. salivarius strains, providing
misleading results.
Contrary to previous data, del Campo and colleagues [25] provided scarce evidence of
S. thermophilus recovery in human feces after daily yogurt consumption. In this study, not a single
positive amplification for S. thermophilus was obtained from the total fecal DNA of 114 volunteers.
The authors attempted to detect S. thermophilus using the THER-F/THER-R primer set, which is
targeted to the lacZ gene. Nevertheless, due to some weaknesses in the protocols adopted for DNA
extraction from fecal samples, the results obtained may have not been correctly analyzed. In addition,
the specificity of the THER-F/THER-R primers for S. thermophiluswas questioned in a later study by
Elli and colleagues [27] who demonstrated that this primer set was not specific enough to set apart
S. salivarius and detect exclusively S. thermophilus. Due to the lack of e cient identification methods,
the same authors carried out a pulsed-field gel electrophoresis (PFGE) based on di↵erent SmaI digested
chromosomes, in order to distinguish these two genetically close species and recover S. thermophilus
from the feces of 20 healthy volunteers who had been consuming commercial yogurt. Likewise, it was
suggested that there is a need for reliable molecular tools for the identification of orally administered S.
thermophilus strains. In a 2012 study, García Hernández and colleagues [9] for the first time applied the
DVC-FISH method to fecal samples for the elucidation of the survival rate of S. thermophilus strain
CECT 801 to GIT transit. It must be observed, however, that the FISH probe used in the study, namely
STH23 targeting the 23S rRNA gene, may not be specific enough for S. thermophilus because only one
single base mismatch was present between the FISH probe target region of S. thermophilus and S.
salivarius. In 2009, Ongol et al. [58] developed a real-time PCR method targeting a gene encoding a 16S
rRNA processing protein (rimM) for the detection of S. thermophilus in dairy products. The authors
tested the primer set against several lactic acid bacteria, including S. salivarius, demonstrating its high
specificity but failed to amplify some S. thermophilus strains.
In light of the scientific literature cited we can, therefore, conclude that to date there are no
taxonomically correct assays that allow tounambiguously identifyS. thermophilus strains anddistinguish
them from those belonging to S. salivarius in a stool sample.
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4.2. Culture-Independent Detection and Identification of S. thermophilus
The problems related to the incorrect identification of S. thermophilus are not limited to the
studies aimed to verify the recovery of live cells in stool samples during intervention studies. We are
living in the microbiota era, and the role of microorganisms is becoming increasingly relevant in
all ecosystems, including the human ecosystem. Several studies have been focused on the role of
diet- and food-associated microorganisms on gut microbiota and human health. The complexity of
the taxonomy of S. thermophilus/S. salivarius/S. vestibularis group was often completely ignored also
in this research field. Francavilla and colleagues [59], in a study aimed to characterize the salivary
microbiota and metabolome associated with celiac disease, reported that S. thermophilus levels in
human saliva were markedly decreased in a group of subjects that undergo a gluten-free diet. In this
study saliva microbiota was characterized by 16S rRNA gene amplicon library sequencing, and the
authors did not take into consideration both the taxonomy and the ecology of the environment they
studied, making the readers erroneously believe that S. thermophilus is a common inhabitant of our oral
cavity. More recently, Pasolli and colleagues [60] published an interesting study aimed to elucidate
to what extent the lactic acid bacteria we ingest through the consumption of fermented food become
members of the gut microbiome. The authors analyzed 9445 metagenomes from human samples and
demonstrated that the prevalence and abundance of lactic acid bacteria species in stool samples is
generally low and linked to age, lifestyle, and geography, with S. thermophilus being one of the most
prevalent species [60]. To reach this conclusion, the authors focused on a defined list of genomes
to be used as reference for the quantification of the prevalence of lactic acid bacteria species in the
human gut, but unfortunately only the genome of S. thermophilus was present in the list, whereas
the genome of S. salivariuswas not considered at all [60] although the latter is recognized as a major
human commensal [30]. Therefore, how can we provide adequate scientific evidence towards the
statement that the increased consumption of yogurts and other dairy products are the sources of
S. thermophilus in our gut ecosystem? Moreover, which metabolic features of S. thermophilus would
guarantee adaptation of this species to the human gut environment? Why did the authors not consider
that S. thermophilus was described as an example of genomic regressive evolution for adaptation to the
milk environment [33,34]? In other studies [61,62] aimed to find correlation between the diet and the
gut microbiota composition, where the proper reference genomes have been used, S. thermophilus was
not considered as a human gut inhabitant.
5. Conclusions
Growing interest in the probiotic market, together with the increasing number of single and
multi-strain products, is not always accompanied by scientific studies aimed to address the health
benefit on the host of such products. In the last few years, some e↵orts have been made to evaluate the
quality levels of products that are commercialized [63–67]. However, limited e↵orts have been made
to develop molecular or phenotypic tools able to accurately identify the species and/or the strains
administered as probiotics in intervention studies. The accurate taxonomic identification is, therefore,
a paramount issue to be validated for the compliance of probiotic food and supplement products.
Without a correct taxonomy assignment of the species/strains that should contain probiotic traits, the
interpretation of the results obtained from the intervention studies is thwarted. This is especially the
case of S. thermophilus, whose probiotic status has been in debate for decades. Being S. thermophilus a
species with high economic relevance for the probiotic market, and S. salivarius one of the major human
commensals able to colonize several human body-related sites, including the digestive tract [30], the
correct identification of these taxa should be of high interest for the food and pharma industry. Another
important issue arising from the reviewed literature is the absence of guidelines and protocols for the
recovery from stool samples of orally ingested probiotics. The guidelines should recommend a proper
study design based on a double-blind, placebo-controlled crossover design, an appropriate washout
period together with the application of a species-specific plate culture method (if available), and/or the
use of strain-specific molecular tools to correctly identify the orally administered probiotic/s. Moreover,
Nutrients 2020, 12, 2175 9 of 12
among the commonly adopted exclusion criteria used in the intervention studies (e.g., antibiotic
consumption prior to the start of the study, consumption of antacids or prokinetic gastrointestinal
drugs, history or presence of significant intestinal diseases) the exclusion of the subjects showing a
positive detection of probiotic strain in fecal samples during the run in or the placebo intake period
should be considered because it might represent a possible compliance violation due to unauthorized
probiotic intake.
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